IDEXX Laboratories stock sits 36.51 percent below USD 747.00 target
Published on 10/15/2026 at 22:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTarget and reporting date
- The average 12-month target is USD 747.00 from 11 analyst ratings on October 15, 2026, 36.51 percent above the primary-exchange price.
- IDEXX Laboratories is scheduled to release third-quarter 2026 results on November 2, 2026.
- IDEXX Laboratories stock costs EUR 487.95 at 10:36 p.m. CEST at Lang & Schwarz on October 15, 2026.
- IDEXX Laboratories has a USD 43.1 billion market capitalization and a P/E ratio of 38.75.
IDEXX Laboratories stock sits 36.51 percent below the USD 747.00 average 12-month target compiled from 11 analyst ratings, according to MarketBeat on October 15, 2026. IDEXX Laboratories is scheduled to release its third-quarter 2026 financial results on November 2, 2026, according to an IDEXX Laboratories release dated October 1, 2026. The euro quote was at EUR 487.95 at Lang & Schwarz on October 15, 2026 at 10:36 p.m. CEST.
November 2 results date
The next reporting date gives investors a defined calendar point for the company. IDEXX Laboratories said the third-quarter release will come before the US market opens, followed by an analyst conference call at 8:30 a.m. ET, according to the October 1, 2026 release linked above.
The company describes its business as veterinary diagnostics, software and water-testing products and services. Its Nasdaq listing is identified as IDXX, and the company is a member of the S&P 500, according to the same release.
Valuation and analyst spread
The USD 747.00 average target compares with a primary-exchange price of USD 547.18 on October 15, 2026. That produces a 36.51 percent target premium when both figures are measured in USD.
IDEXX Laboratories had a market capitalization of USD 43.1 billion and a P/E ratio of 38.75 as of October 15, 2026. The 52-week range was USD 500.61 to USD 769.98, placing the primary-exchange price between those two levels.
Trading position after hours
The Lang & Schwarz euro quote was EUR 487.95 at 10:36 p.m. CEST on October 15, 2026. The latest primary-exchange quote was USD 547.18 at 4:00 p.m. ET on the Nasdaq, while reported volume stood at 545,018 shares against an average of 544,901 shares.
IDEXX Laboratories' price remains well below its USD 769.98 52-week high and above its USD 500.61 low. The upcoming November 2 report is therefore the next dated company event in this market snapshot.
Euro quote and investor calendar
The current euro quotation and the November 2 reporting date provide two separate reference points for investors following IDEXX Laboratories. The company has scheduled the results before the US opening bell, making the release timing explicit for European market participants.
The further course of trading is shown by the continuously updated real-time quote of IDEXX Laboratories stock.
IDEXX Laboratories market data
- Company: IDEXX Laboratories, Inc.
- ISIN: US45168D1046
- Ticker: IDXX
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 10:36 p.m. CEST): EUR 487.95
- Market capitalization: USD 43.1 billion (as of October 15, 2026)
- 52-week range: USD 500.61-769.98 (as of October 15, 2026)
- Sector / Industry: Health Care / Veterinary diagnostics
- Index membership: S&P 500
- Next earnings date: November 2, 2026
Market context: Market report S&P 500.
